The company’s sales in India were recorded at Rs 3,460 crore, a rise of 8.5 per cent against the second quarter of last year. At the same time, the sales in the US were up by 27.5 per cent quarter on quarter and stood at USD 200 million
The pharma company’s net profit slumped by 1 per cent year on year (YoY) and stood at Rs 312 crores in the second quarter from Rs 316 crores in the previous year
Your e-mail iformation will not be shared with anyone else. And it will be used only to send out our latest news.